AmnioGraft -Biologic Ocular Transplantation Graft Tissue
AmnioGraft is a biologic ocular transplantation graft used by eye surgeons around the world as an adjunct therapy to treat ocular surface indications such as corneal ulcers, pterygium, mechanical dry eye (also known as conjunctivochalasis), excision of tumors, chemical burns, and Stevens-Johnson Syndrome. AmnioGraft serves as a tissue replacement by delivering the unique therapeutic actions of cryopreserved amniotic membrane.
Expedite Recovery, Promote Regenerative Healing
AmnioGraft expedites patient recovery by reducing inflammation and scarring, promoting regenerative healing, and achieving a superior cosmetic outcome. This is particularly beneficial to many ocular surface diseases and conditions to ameliorate pain, vision loss, and in some cases an undesirable ocular cosmetic appearance.
The Healing Process
AmnioGraft is durable and easy to use, and provides lasting cosmetic results. After surgery, full healing is typically complete in two to three weeks.
Amniotic membrane is part of the placenta. It is the tissue closest to the baby throughout development in the womb. The biological properties of amniotic membrane protects the baby from any harm and its natural therapeutic actions helps the baby develop.
The placentas used to prepare AmnioGraft are donated by consenting mothers after cesarean section births. Mothers that donate are fully informed, have healthy lifestyles, and are tested against infectious diseases prior to donation.